Clinical research goes beyond trials: projects and initiatives drive innovation and open new perspectives for the medicine of tomorrow.
Current Projects and Activities:
Diacerein 2: This study investigates the wound-healing effects and safety of ointment therapy for EB simplex subtypes.
ServEB: The goal of this project is to develop an automated digital measurement system and AI-supported assessment of EB wounds, for example with regard to their cancer risk. The program is intended to be made available as an app for easy use at home.
COSEB: In this project, an international team aims to agree on the key measurement parameters and instruments for the various EB subtypes in order to conduct more comparable clinical studies in the future and obtain more meaningful results.
Other projects focus on the use of new antibiotic wound sprays and anti-inflammatory medications in EB, epidemiological studies on the spectrum and burden of EB and EB-associated skin cancer, the systematic documentation of EB treatments previously reported in the scientific literature, the accuracy of different diagnostic methods for EB, the reasons why clinical trials fail or cannot be successfully completed, the identification of relevant inflammatory mediators in EB that can be therapeutically targeted with available drugs, as well as and the prevalence and types of allergies in EB patients.
From Research to Treatment: Clinical trials are a key step in advancing medical care. Learn how they work and why they are important for developing new therapies.
